Botox Azzalure — Upper Face

Upper face Botox treatment using Azzalure (botulinum toxin type A) targeting forehead lines, glabellar frown lines, and crow's feet. Administered by aesthetic medicine physicians at Bona Dea's Kraków clinic with over 25 years of injectable experience.

The Botox Azzalure upper face treatment at Bona Dea targets the three primary dynamic wrinkle zones of the upper face: horizontal forehead lines, the vertical frown lines between the eyebrows (glabella), and the lateral crow's feet around the eyes. Azzalure is a European-manufactured botulinum toxin type A product (Galderma) with a well-established safety profile and predictable onset of action, typically 3 to 5 days with full effect visible by day 14. The procedure itself takes approximately 20 minutes including consultation, marking of injection points, and administration. Bona Dea's physicians use a micro-dose technique refined over more than two decades of practice, placing precise quantities of toxin at calculated points along the frontalis, corrugator, procerus, and orbicularis oculi muscles. This approach aims for natural-looking relaxation of overactive muscles while preserving forehead mobility and brow position — avoiding the frozen or expressionless appearance associated with over-treatment. Results from a single session typically last 3 to 4 months, though patients who maintain a regular treatment schedule often find that muscle activity weakens over time, allowing longer intervals between sessions. Bona Dea recommends a follow-up review at 2 weeks post-injection to assess symmetry and make any refinement injections if needed. No anaesthesia is required; the needles used are ultra-fine (30-32 gauge) and most patients report only minimal discomfort. There is no downtime — patients can return to normal activities immediately, with the standard advice to avoid lying flat or massaging the treated area for 4 hours post-injection.